Blunted Cortisol Responses to THC Did Not Establish Lower THC Exposure

Frequent cannabis users showed smaller cortisol increases after intravenous THC in pooled human research. The result concerns a hormonal response, not proof that those participants absorbed less THC or were unaffected in every other function.

A pooled analysis of two studies

Investigators analyzed 40 frequent users and 36 controls across controlled intravenous THC experiments. Hormones were assessed in plasma, with post-dose values analyzed while accounting for baseline levels. The use-history groups were not randomized to become frequent users.

Responses differed, but concentrations did not track the same way

THC raised plasma cortisol in a dose-related manner, with a blunted increase among frequent users. Baseline cortisol was similar between groups. Frequent users also had lower baseline prolactin, which is a different hormone and comparison.

The exposure analysis had its own denominator

Plasma THC and THC-COOH were analyzed in 52 of the 76 participants. Parent THC increased with dose without significant group differences or a group-by-dose interaction. Frequent users had higher baseline THC-COOH, an inactive metabolite. Attaching the full 76-person denominator to every concentration result would be incorrect.

Tolerance remains an interpretation

The hormonal pattern is compatible with tolerance, but pre-existing group differences cannot be excluded. Sampling times differed across the pooled studies, baseline early-morning cortisol was not assessed, and the small number of women limited sex-related analyses. A cortisol value cannot diagnose cannabis impairment, establish a person’s stress experience or convert into a THC concentration. The study supports separating exposure from a particular physiological response.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Ranganathan M; Braley G; Pittman B; Cooper T; Perry E; Krystal J; D’Souza DC. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (2009). DOI: 10.1007/s00213-008-1422-2.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

Adding CBD was associated with less first-day vomiting in a small adolescent-primate experiment, but did not prevent the measured THC-related learning disruption. Improvement in one adverse outcome should not be presented as general protection. Three small treatment groups Twelve male squirrel monkeys received vehicle, THC alone or THC with CBD,…

Spread the love

Read Article: Less Vomiting With CBD Did Not Mean Protection From THC’s Cognitive Effects in Primates

A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

A cannabinoid-receptor mutation associated with altered tolerance in other experiments did not delay THC tolerance in mice with cisplatin-related neuropathy. The result shows why a mechanism demonstrated in one pain model may not transfer to another. A chronic pain model with two sexes Researchers studied wild-type mice and animals carrying…

Spread the love

Read Article: A Receptor Mutation Did Not Delay THC Tolerance in a Chemotherapy-Neuropathy Model

Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Behavior after cannabinoid cessation differed with the compound, dose and observation time in a mouse study. An early negative assessment could miss later changes, while a strong response to a synthetic agonist should not be relabeled as a THC result. Continuous observation added information Researchers compared repeated THC with AM2389,…

Spread the love

Read Article: Mouse Cannabinoid Withdrawal Findings Depended on Timing and Agonist Efficacy

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us